Share
The world now has a new Covid-19 vaccine in its arsenal, and at a fraction of the cost per dose.
Unlike the three vaccines approved in the U.S. – Pfizer and Moderna’s mRNA vaccines and Johnson & Johnson’s viral vector vaccine, which provide the body instructions on how to produce the spike protein – the new CORBEVAX vaccine delivers the spike protein to the body directly. Like those other approved COVID-19 mRNA vaccines, CORBEVAX also requires two doses.
But this vaccine can be produced at a much larger scale because appropriate manufacturing facilities are already available. Also key to global access is that CORBEVAX can be stored in a regular refrigerator. Therefore, it is possible to produce millions of doses rapidly and distribute them relatively easily.
Another major difference is that the CORBEVAX vaccine was developed with global vaccine access in mind. The goal was to make a low-cost, easy-to-produce-and-transport vaccine using a well-tested and safe method.
Read more from Civil Beat
RELATED TOPICS:
Dollar Trades Lower With Fed Cut In View, On Course For Monthly Drop
3 hours ago
Visalia Semi Crash Injures Amazon Truck Driver After Red Light Collision
3 hours ago
Evacuation of Gaza City Would Be Unsafe and Unfeasible, Says Head of Red Cross
3 hours ago
Most Trump Tariffs Are Not Legal, US Appeals Court Rules
3 hours ago
New $250 Visa Fee Risks Deepening US Travel Slump
3 hours ago
Prime Minister of Yemen’s Houthi Government Killed in Israeli Strike
3 hours ago
California Schools Reverse Truancy Trends. Improving Reading Scores Could Be Next
3 hours ago
Judge Blocks Pillar of Trump’s Mass Deportation Campaign
4 minutes ago
Categories

Judge Blocks Pillar of Trump’s Mass Deportation Campaign

Visalia Driver Arrested for DUI After Multiple Crashes and Pedestrian Injured

Dollar Trades Lower With Fed Cut In View, On Course For Monthly Drop

Visalia Semi Crash Injures Amazon Truck Driver After Red Light Collision

Evacuation of Gaza City Would Be Unsafe and Unfeasible, Says Head of Red Cross
